Ser94
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser94  -  BIM (human)

Site Information
sLLSRSssGyFsFDT   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 4698178

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 2 , 3 , 4 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
AurA (human) ( 1 )
Kinases, in vitro:
AurA (human) ( 1 )
Putative upstream phosphatases:
PPP2CA (human) ( 1 )
Treatments:
BI-D1870 ( 1 ) , C2-ceramide ( 1 ) , MLN8054 ( 1 ) , nocodazole ( 1 ) , okadaic_acid ( 1 ) , RO-3306 ( 1 ) , siRNA ( 1 )

Downstream Regulation
Effects of modification on BIM:
molecular association, regulation ( 1 ) , protein degradation ( 1 ) , ubiquitination ( 1 )
Induce interaction with:
BTRC (human) ( 1 )

References 

1

Moustafa-Kamal M, et al. (2013) BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by ╬▓TrCP1. Cell Death Differ 20, 1393-403
23912711   Curated Info

2

Mertins P, et al. (2013) Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 10, 634-7
23749302   Curated Info

3

Zhou H, et al. (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 12, 260-71
23186163   Curated Info

4

Mayya V, et al. (2009) Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2, ra46
19690332   Curated Info